DENVER — After working for decades in a field littered with promising but failed clinical trials, a prominent researcher inAccording to the gene-time hypothesis, duration of exposure to noxious chemicals and genetic susceptibility are key drivers of ALS risk, explained Eva Feldman, MD, PhD, director of the ALS Center of Excellence at the University of Michigan, Ann Arbor, Michigan. She believes that existing research in risk modification is already promising.
"I spent 10 years trying to repurpose IGF-1 as an ALS therapy. We took it from preclinical work all the way to a phase 3 multicenter trial, but in the end no effect was seen," Dr. Feldman said. There is already substantial support for the underlying time-gene hypothesis, according to Dr. Feldman. Among several examples, she described work with 122 POPS that appear individually and in many cases collectively to correlate with ALS risk. Recent work with an environmental risk score that permits studies of risk when accounting for exposure to families of pollutants, has supported these as potentially modifiable risks.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Prominent Figure in German Far-right Party Going on Trial over Alleged Use of Nazi SloganOne of the most prominent figures in the farright Alternative for Germany party is going on trial Thursday on charges of twice using a Nazi slogan, months before a regional election in which he is running to become his state's governor.Björn Höcke, 52, is the leader of the...
Source: NEWSMAX - 🏆 16. / 71 Read more »
Source: sdut - 🏆 5. / 95 Read more »
Source: ksatnews - 🏆 442. / 53 Read more »
Source: wjxt4 - 🏆 246. / 63 Read more »
Source: AP - 🏆 728. / 51 Read more »